AMD Expert Column Series Comparison of Recent AMD Clinical Trials: An Evidence- Based Approach to Treating AMD Patients

Age-related macular degeneration (AMD) is the leading cause of blindness in patients over the age of 50 years in industrialized countries.[1] There are 2 types of macular degeneration, the nonexudative (dry) and exudative (neovascular) forms. Although the nonexudative form is in general milder, patients with geographic atrophy that occurs in the fovea will experience sever